Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / NYLI FTSE INTERN
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
9,846,147
-
Shares change
-
+348,930
-
Total reported value, excl. options
-
$189,724,000
-
Value change
-
+$6,253,948
-
Number of buys
-
18
-
Number of sells
-
-12
-
Price
-
$19.27
Significant Holders of NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) as of Q3 2022
37 filings reported holding HFXI - NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN as of Q3 2022.
NEW YORK LIFE INVESTMENTS ET - NYLI FTSE INTERN (HFXI) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,846,147 shares
.
Largest 10 shareholders include NEW YORK LIFE INVESTMENT MANAGEMENT LLC (5,752,656 shares), UBS Group AG (1,500,069 shares), MORGAN STANLEY (496,305 shares), BANK OF AMERICA CORP /DE/ (315,271 shares), Raymond James Financial Services Advisors, Inc. (298,489 shares), COMMONWEALTH EQUITY SERVICES, LLC (272,258 shares), LPL Financial LLC (240,894 shares), AMERIPRISE FINANCIAL INC (165,920 shares), Ten Capital Wealth Advisors, LLC (134,422 shares), and ROYAL BANK OF CANADA (133,494 shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.